Skip to content
GLP-1 Savers
Menu
Ranked #100 · Fair Price

Medro review

Medro (Medro Health Technologies, Inc.) is a telehealth brand whose GLP-1 program offers compounded semaglutide and tirzepatide, plus brand-name GLP-1s when eligible, via a partner medical group.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $199/mo

Save ~85% vs brand-name

From $199/mo (compounded)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The published figure is a single-tier rate, not a price that is guaranteed at every dose.

How much does Medro cost?

The price Medro publishes is From $199/mo (compounded). Tirzepatide is listed at From $299/mo (compounded). We flag this one to watch: confirm the ongoing rate with Medro before you count on it, because a low first month can step up afterward. That works out about 85% under our ~$1,349/mo brand-name cash reference.

Semaglutide
From $199/mo (compounded)
Tirzepatide
From $299/mo (compounded)
Coverage
All 50 states
Brand-name
Yes

The Value Score card

Medro scored on our six published factors. See the methodology.

Lowest Real Price72/100
No Teaser-Rate Bait60/100
Nationwide Availability96/100
Both Molecules92/100
Easy Cancellation95/100
Reputation64/100

Why it's a deal

  • Covers both compounded semaglutide and tirzepatide and can prescribe brand-name GLP-1s when clinically appropriate.
  • LegitScript-certified (seal #50716646), available in all 50 states, with tiered pricing shown before checkout.
  • No membership fee and free expedited shipping on all orders; online intake with no appointment required in many cases.
  • Prices drop with longer commitments (semaglutide to $149/mo, tirzepatide to $224/mo on a 12-month plan).

Read the fine print

  • Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.
  • Pricing is described as illustrative and may change by dose, pharmacy availability, and eligibility — final cost shows only at checkout.
  • Very new brand (2026, trademark pending) spanning many verticals, with a short track record in GLP-1 care.
  • Compounded medications are not FDA-approved or therapeutically equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound.

The bottom line

Best for: Shoppers who want compounded or brand semaglutide/tirzepatide with transparent tiered pricing and no membership, all 50 states. Medro (Medro Health Technologies, Inc.) is a telehealth brand whose GLP-1 program offers compounded semaglutide and tirzepatide, plus brand-name GLP-1s when eligible, via a partner medical group.

Ranked #100 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Medro, out of 426 others we track.

Shopping Medro against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Medro, and every program that undercuts or outscores it — starting with Auren Rx, the closest match on score — is ranked on the Medro alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Medro's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Medro's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals